LOS ANGELES--(BUSINESS WIRE)--Apr 21, 2025--
Belkin, a leading consumer electronics brand for 40 years, today published its 2024 Impact Report, announcing its milestone achievement of carbon neutrality in scope 1 and scope 2 emissions, and underscoring its commitment to sustainability and corporate responsibility. With bold progress in carbon reduction and sustainable product design, Belkin remains steadfast in its commitment to finding more responsible ways to build products that enhance lives while preserving the planet for future generations.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250421326773/en/
“Belkin recently surpassed a monumental milestone: over 1 billion products sold globally. As we reflect on this achievement, we recognize that with scale comes a profound responsibility – to our customers, to the planet, and to future generations,” said Steven Malony, CEO of Belkin. “As we reflect on our 2024 Impact Report, we recognize the progress we’ve made and the work still ahead. We are actively transitioning to post-consumer recycled (PCR) materials across our product lines, using 100% plastic-free packaging, and investing in long-term sustainability strategies to achieve our larger goals of carbon neutrality across our entire business by 2030. Our mission goes beyond creating accessories that empower people to get more life out of every single day – it’s about driving positive change for the planet and its people.”
In the last 12 months, on its journey to carbon neutrality in all scopes by 2030 and in line with its commitment to the UN Sustainable Development Goals, Belkin has achieved:
Climate action (UN Goal 13)
Responsible consumption and production (UN Goal 12)
Made with recycled materials
Two years since introducing its transition to using 72-75% post-consumer recycled (PCR) materials in its products, Belkin has transitioned over 359 products and has replaced 432 metric tons of virgin plastics with PCR materials. This year, several of Belkin’s most popular chargers and cables will receive updated product housing materials that consist of 85-90% PCR and will be certified by the Global Recycling Standard and sold in plastic-free packaging. This initiative is estimated to reduce CO2-eq emissions for these product housing materials by up to 85%.
Award-winning initiatives
Belkin is proud to announce an important achievement in its sustainability journey: receiving a Silver Medal rating from EcoVadis, the globally recognized leader in sustainability ratings. This recognition reflects the company’s ongoing dedication to responsible business practices and positions Belkin among the top-performing companies in the consumer electronics sector evaluated by EcoVadis. Belkin’s overall score ranks in the top 15% globally (91st Percentile) among companies in our industry assessed by EcoVadis.
Shaping a more responsible future
Looking ahead, Belkin remains dedicated to achieving carbon neutrality in all scopes by 2030 and continuously refining its strategy to build products more responsibly. The company is actively investing in circular design principles and exploring innovative ways to further reduce environmental impact without compromising performance or quality.
For more information on Belkin’s sustainability initiatives, visit www.belkin.com/company/sustainability/.
About Belkin
Belkin is a California-based accessories leader delivering award-winning power, protection, productivity, connectivity, and audio products over the last 40 years. Designed and engineered in Southern California and sold in more than 100 countries around the world, Belkin has maintained its steadfast focus on research and development, community, education, sustainability and most importantly, the people it serves. From our humble beginnings in a Southern California garage in 1983, Belkin has become a diverse, global technology company. We remain forever inspired by the planet we live on, and the connection between people and technology.
Belkin achieves carbon neutrality in scope 1 and scope 2 emissions
President Donald Trump’s administration released a lengthy review of transgender health care on Thursday that advocates for a greater reliance on behavioral therapy rather than broad gender-affirming medical care for youths with gender dysphoria.
The 409-page Health and Human Services report questions standards for the treatment of transgender youth issued by the World Professional Association for Transgender Health and is likely to be used to bolster the government’s abrupt shift in how to care for a subset of the population that has become a political lightning rod.
Major medical groups and those who treat transgender young people sharply criticized the new report as inaccurate.
This “best practices” report is in response to an executive order Trump issued days into his second term that says the federal government must not support gender transitions for anyone under age 19.
“Our duty is to protect our nation’s children — not expose them to unproven and irreversible medical interventions,” National Institutes of Health Director Dr. Jay Bhattacharya said in a statement. “We must follow the gold standard of science, not activist agendas.”
The report questions the ethics of medical interventions for transgender young people, suggesting that adolescents are too young to give consent to life-changing treatments that could result in future infertility. It also cites and echoes a report in England that reinforced a decision by its public health services to stop prescribing puberty blockers outside of research settings.
The report accuses transgender care specialists of disregarding psychotherapy that might challenge preconceptions, partly because of a “mischaracterization of such approaches as ‘conversion therapy,’” which about half the states have banned for minors.
The American Academy of Child & Adolescent Psychiatry has said evidence shows conversion therapies inflict harm on young people, including elevated rates of suicidal thoughts.
HHS said its report does not address treatment for adults, is not clinical guidance and does not make any policy recommendations. However, it also says the review “is intended for policymakers, clinicians, therapists, medical organizations, and importantly, patients and their families,” and it declares that medical professionals involved in transgender care have failed their young patients.
The report could create fear for families seeking care and for medical providers, said Shannon Minter, the legal director at the National Center for Lesbian Rights. “It’s very chilling to see the federal government injecting politics and ideology into medical science,” Minter said.
“It’s Orwellian. It is designed to confuse and disorient,” Minter added.
Child and adolescent psychiatrist Dr. Scott Leibowitz, a co-author of the influential WPATH standards for youth, said the new report “legitimizes the harmful idea that providers should approach young people with the notion that alignment between sex and gender is preferred, instead of approaching the treatment frame in a neutral manner.”
While Health Secretary Robert F. Kennedy Jr. has repeatedly pledged to practice “radical transparency,” his department did not release any information about who authored the study. The administration says the new report will go through a peer-review process and will only say who contributed to the report after “in order to help maintain the integrity of this process.”
The report contradicts American Medical Association guidance, which urges states not to ban gender-affirming care for minors, saying that “empirical evidence has demonstrated that trans and non-binary gender identities are normal variations of human identity and expression.”
It also was prepared without input from the American Academy of Pediatrics, according to its president, Dr. Susan Kressly.
“This report misrepresents the current medical consensus and fails to reflect the realities of pediatric care,” Kressly said. She said the AAP was not consulted “yet our policy and intentions behind our recommendations were cited throughout in inaccurate and misleading ways.”
Dr. Jack Drescher, a New York psychiatrist and psychoanalyst who works on sexual orientation and gender identity issues, said the report is one-sided and “magnifies the risks of treatments while minimizing benefits.”
The Trump administration’s report says “many” U.S. adolescents who are transgender or are questioning their gender identity have received surgeries or medications. In fact, such treatments remain rare as a portion of the population. Fewer than 1 in 1,000 adolescents in the U.S. received gender-affirming medication — puberty blockers or hormones — according to a five-year study of those on commercial insurance released this year. About 1,200 patients underwent gender-affirming surgeries in one recent year, according to another study.
Gender-affirming care for transgender youth under standards widely used in the U.S. includes developing a plan with medical experts and family members that includes supportive talk therapy and can — but does not always — involve puberty blockers or hormone treatment. Many U.S. adolescents with gender dysphoria may decide not to proceed with medications or surgeries.
Jamie Bruesehoff, a New Jersey mom, said her 18-year-old daughter, who was assigned male at birth, identified with girls as soon as she could talk. She began using a female name and pronouns at 8 and received puberty blockers at 11 before eventually beginning estrogen therapy.
“She is thriving by every definition of the word,” said Bruesehoff, who wrote a book on parenting gender-diverse children. “All of that is because she had access to this support from her family and community and access to evidence-based gender-affirming health care when it was appropriate.”
A judge has blocked key parts of Trump’s order, which includes denying research and educational grants for medical schools, hospitals and other institutions that provide gender-affirming care to people 18 or younger. Several hospitals around the country ceased providing care. The White House said Monday that since Trump took office, HHS has eliminated 215 grants totaling $477 million for research or education on gender-affirming treatment.
Most Republican-controlled states have also adopted bans or restrictions on gender-affirming care. A U.S. Supreme Court ruling is pending after justices heard arguments in December in a case about whether states can enforce such laws.
The Jan. 28 executive order is among several administration policies aimed at denying the existence of transgender people. Trump also has ordered the government to identify people as either male or female rather than accept a concept of gender in which people fall along a spectrum, remove transgender service members from the military, and bar transgender women and girls from sports competitions that align with their gender. This month, HHS issued guidance to protect whistleblowers who report doctors or hospitals providing gender-affirming care. Judges are blocking enforcement of several of the policies.
This latest HHS report, which Trump called for while campaigning last year, represents a reversal in federal policy. The U.S. Substance Abuse and Mental Health Services Administration, which is part of HHS, found that no research had determined that behavioral health interventions could change someone’s gender identity or sexual orientation. The 2023 update to the 2015 finding is no longer on the agency’s website.
FILE - Health and Human Services Secretary Robert F. Kennedy Jr. speaks at the Rx and Illicit drug Summit, April 24, 2025, in Nashville, Tenn. (AP Photo/George Walker IV, File)
FILE - Children hold signs and transgender pride flags as supporters of transgender rights rally by the Supreme Court, Dec. 4, 2024, in Washington. (AP Photo/Jacquelyn Martin, File)
File - Supporters of transgender rights rally by the Supreme Court, Dec. 4, 2024, in Washington. (AP Photo/Jacquelyn Martin, File)
FILE - President Donald Trump holds up an executive order after signing it at an indoor Presidential Inauguration parade event in Washington, Jan. 20, 2025. (AP Photo/Matt Rourke, File)
